Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02392676
Title Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations
Recruitment Withdrawn
Gender female
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Research Site Mobile Alabama United States Details
Research Site Phoenix Arizona United States Details
Research Site Los Angeles California United States Details
Research Site Stanford California United States Details
Research Site Augusta Georgia United States Details
Research Site Park Ridge Illinois United States Details
Research Site Iowa City Iowa United States Details
Research Site Louisville Kentucky United States Details
Research Site Covington Louisiana United States Details
Research Site Scarborough Maine United States Details
Research Site Baltimore Maryland United States Details
Research Site Albany New York United States Details
Research Site Oklahoma City Oklahoma United States Details
Research Site Philadelphia Pennsylvania United States Details
Research Site Milwaukee Wisconsin United States Details
Research Site Goyang-si Korea, Republic of Details
Research Site Seongnam-si Korea, Republic of Details
Research Site Seoul Korea, Republic of Details
Research Site Chiclayo Peru Details
Research Site Lima Peru Details
Research Site Quezon City Philippines Details
Research Site Birmingham United Kingdom Details
Research Site Cambridge United Kingdom Details
Research Site Coventry United Kingdom Details
Research Site Edinburgh United Kingdom Details
Research Site London United Kingdom Details
Research Site Manchester United Kingdom Details
Research Site Oxford United Kingdom Details
Research Site Sutton United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field